Therapeutic use of cannabinoids under medical prescription
DOI:
https://doi.org/10.51481/amc.v49i2.308Keywords:
Cannabis sativa, marihuana, cannabinoids, medical use, therapeutical effectAbstract
We hereby present the case of a 39 year old, USA tourist, who complained of cervical arthrosis and was accused of drug smuggling when he arrived to Costa Rica. However, he claimed that his marihuana had been prescribed to him in his country as symptomatic treatment. We analyse the potential therapeutic use of cannabinoids as pain reliever, appetite stimulant and for nausea and vomiting control. Therefore, it might be possible that in few years from now, physicians could find new medicines obtained from endocannabinoids for the treatment of diverse entities. Finally, in this particular case due to the patient´s citizenship, his genuine cervical illness and the clinical signs of marihuana chronic use; it could be possible that the drug was indeed prescribed by his doctor.
Downloads
References
Tullio, A. Diccionario médico-legal. Buenos Aires, Argentina: Abeledo-Perrot, 1999. Pág:166
Córdoba, D. Toxicología. 4 ed. Bogotá: Manual Moderno; 2000: 420-1.
Bell G, Hall A. CBRNE-Incapacitating Agents, Cannabinoids. eMedicine World Medical Library. 2006 may 23. Accedido el 8 de julio de 2006 en: http://www.emedicine.com/emerg/topic921.htm
Waldo, A. History of cannabis as a medicine: a review. Rev Bras Psiquiatr. 2006;28:153-7.
Calabuig, G. Medicina legal y toxicología. 6 ed. Barcelona: Masson; 2005:1023-24.
Joy J, Watson S, Benson, J. Marijuana and Medicine: Assessing the Science Base. Institute of Medicine National Academy Press.
Washington, D.C; 1999. accedido 8 de julio de 2006 en http://www. ukcia.org/research/iom1999/default.htm
Ministerio de Salud de Costa Rica. Ley No. 7600 del 2 de mayo de 1996. Ley General de Salud, capítulo I, sección III, párrafo 4.
Sugiura T, Oka S, Gokoh M, Kishimoto S and Waku K. New perspectives in the studies on endocannabinoid and cannabis: 2Arachidonoylglycerol as a possible novel mediator of inflammation. J Pharmacol Sci 2004, 96, 367-375.
Rodríguez, F. Sistema endocannabinoide y control de la ingesta. Rev Med Univ Navarra. 2004; 48: 18-23.
Meng ID, Manning BH, Martin WJ and Fields HL. An analgesia circuit activated by cannabinoids. Nature. 1998;395:381-383
Swift, W; Gates, P; Dillon, P; Survey of Australians using cannabis for medical purposes. Harm Reduction Journal. 2005, 2:18. Accedido el 8 de Julio de 2006 en http://www.harmreductionjournal.com/ content/2/1/1.
Abrams, D; Hilton, J; Leiser, R; Shade, S; Elbeik T, Aweeka, F; Benowitz, N, et al. Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection A Randomized, Placebo-Controlled Clinical Trial. Annals. 2003; 139: 258-266.
Sibbald, B. Conditional okay for cannabis prescription drug. JAMC. Jun 2005; 172: 1672.
Marinol®. 2005. Accedido el 10 de julio de 2006 en: http://www.
marinol.com/pdfs/MARINOLPI.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
